Cecilia L Moore - JoVE Visualize

Showing results (1-10 of 20) with videos related to

Pageof 2

Sort By:

Journal of Clinical Epidemiology|February 3, 2016

Poor record linkage sensitivity biased outcomes in a linked cohort analysisCecilia L Moore, Heather F Gidding, Matthew G Law, et al.

Plos One|July 29, 2014

A new method for assessing how sensitivity and specificity of linkage studies affects estimationCecilia L Moore, Janaki Amin, Heather F Gidding, et al.

The Lancet. HIV|May 4, 2019

Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventionsCecilia L Moore, Wolfgang Stöhr, Angela M Crook, et al.

AIDS (London, England)|March 3, 2015

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levelsWilliam J Hey-Cunningham, John M Murray, Ven Natarajan, et al.

Plos One|November 9, 2013

HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapyAllison Martin, Cecilia L Moore, Patrick W G Mallon, et al.

AIDS and Behavior|February 4, 2016

Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual MenCecilia L Moore, Heather F Gidding, Fengyi Jin, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016

Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual MenCecilia L Moore, Andrew E Grulich, Garrett Prestage, et al.

Antiviral Therapy|April 28, 2017

Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trialAmanda H Yao, Cecilia L Moore, Poh Lian Lim, et al.

AIDS Research and Human Retroviruses|June 28, 2016

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE StudyEdward P Lam, Cecilia L Moore, Eduardo Gotuzzo, et al.

The Lancet. HIV|October 2, 2015

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysisMark A Boyd, Cecilia L Moore, Jean-Michel Molina, et al.

Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:

Pageof 2

Journal of Clinical Epidemiology|February 3, 2016

Poor record linkage sensitivity biased outcomes in a linked cohort analysisCecilia L Moore, Heather F Gidding, Matthew G Law, et al.

Plos One|July 29, 2014

A new method for assessing how sensitivity and specificity of linkage studies affects estimationCecilia L Moore, Janaki Amin, Heather F Gidding, et al.

The Lancet. HIV|May 4, 2019

Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventionsCecilia L Moore, Wolfgang Stöhr, Angela M Crook, et al.

AIDS (London, England)|March 3, 2015

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levelsWilliam J Hey-Cunningham, John M Murray, Ven Natarajan, et al.

Plos One|November 9, 2013

HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapyAllison Martin, Cecilia L Moore, Patrick W G Mallon, et al.

AIDS and Behavior|February 4, 2016

Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual MenCecilia L Moore, Heather F Gidding, Fengyi Jin, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016

Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual MenCecilia L Moore, Andrew E Grulich, Garrett Prestage, et al.

Antiviral Therapy|April 28, 2017

Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trialAmanda H Yao, Cecilia L Moore, Poh Lian Lim, et al.

AIDS Research and Human Retroviruses|June 28, 2016

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE StudyEdward P Lam, Cecilia L Moore, Eduardo Gotuzzo, et al.

The Lancet. HIV|October 2, 2015

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysisMark A Boyd, Cecilia L Moore, Jean-Michel Molina, et al.

Pageof 2